Suggestions
Stefan Scherer
Chief Executive Officer at ElyxBio
Professional Background
Stefan Scherer is a highly accomplished executive with a wealth of experience in drug development, clinical science, and translational medicine. As the Chief Executive Officer at Elyxbio, he plays a pivotal role in steering the company towards success, utilizing his extensive background in overseeing development strategies for both early and late-stage assets. His extensive career spans various prestigious organizations, where he has held key leadership positions, making significant contributions to the fields of medicine, science, and business development.
With a unique blend of expertise in strategic planning, product development, and brand strategy, Stefan is renowned for his ability to foster trusted relationships with both internal and external partners. His exceptional medical and scientific knowledge has established him as a valuable asset in the corporate landscape, where he navigates complex challenges within the healthcare and pharmaceutical industries. His versatility allows him to adapt to diverse functional roles, making him a dynamic leader who enhances organizational effectiveness.
Education and Achievements
Stefan's academic journey is as remarkable as his professional accomplishments. He studied Entrepreneurship and Finance at the prestigious University of Oxford, where he gained insights into the intricate world of business management and strategy. He then pursued a Doctor of Medicine at The University of Freiburg, where he honed his medical acumen, further solidifying his foundation in healthcare.
Stefan's thirst for knowledge later led him to The Julius Maximilians University of Würzburg, where he earned a Doctor of Philosophy in Biology and Chemistry. This interdisciplinary education equipped him with a profound understanding of molecular biology, greatly influencing his career in drug development and clinical science. His academic endeavors began at Heidelberg University, where he received a Bachelor’s degree in Bioinformatics, merging biology and technology, a crucial skill in today's rapidly advancing biotechnology landscape.
His impressive tenure in various organizations showcases his commitment to advancing medical science and enhancing clinical practices. Previously, he served as a Member of the Board at Makucell, contributing his insights to drive innovation in biological research. At GlaxoSmithKline (GSK), he was the Global Head of Experimental Medicine, where his leadership facilitated the exploration of novel therapeutic approaches.
Stefan also held the position of Chief Marketing Officer and Senior Vice President of Clinical Development at Cellectis, where he was instrumental in shaping the company's clinical strategy and promoting its innovative therapies. His experience as Vice President and Head of Early Development, Strategy, and Innovation at Novartis emphasizes his deep involvement in steering product development from conception through clinical phases.
In addition to his role at Novartis, where he was also the Vice President and Head of Academic Medical Innovation, Stefan demonstrated leadership as the Chair of the Strategic Governing Group at the Innovative Medicines Initiative (IMI). He previously served as Vice President and Global Head of Correlative Science at Novartis, showcasing his expertise in unlocking critical biological insights in drug development.
Stefan's earlier career includes significant roles at Biocartis as Chief Medical Officer, where he advanced the company's unique diagnostic approaches, and as the Global Biomarker Head at Genentech. His work as Senior Global Biomarker Program Leader and Head of Biomarker Angiogenesis at Roche further highlights his longstanding commitment to advancing biomarker research, which is critical for personalized medicine. He also made notable contributions as the International Clinical Project Leader at Grünenthal Group and as a Junior Group Leader at the esteemed Albert Einstein College of Medicine.
Achievements
Throughout his distinguished career, Stefan Scherer has amassed a portfolio of achievements that enhance his reputation as a leader in the pharmaceutical and biotech industries. His strategic vision and execution of innovative research projects have led to breakthroughs that enhance patient care and medical outcomes worldwide. By leveraging his comprehensive understanding of disease entities and their molecular implications, he has enabled organizations to not only develop new therapies but also to connect deeply with medical communities and stakeholders.
His focus on fostering academic alliances and partnerships has amplified his ability to drive collaborative initiatives that transcend traditional industry boundaries. This approach has established pathways for innovative scientific explorations, allowing for diverse perspectives in developing groundbreaking medical solutions.
In summary, Stefan Scherer’s career exemplifies extraordinary leadership within the pharmaceutical and biotechnology sectors. His educational foundation, combined with his vast experience in drug development and deep scientific knowledge, positions him as a remarkable figure who continues to influence the advancement of medical science globally.
Highlights

